ATP1B3 and cancer: The results showed that ADA, ATP1B3, DYNC1H1 and FTCD were differently expressed in non-cancer vs. cancer tissues of different stages, in cancer tissues of stage I vs. stage II or stage I vs. stage III (Additional file 4: Fig. S4).